ProShares Ultra NASDAQ Biotechnology
17 hedge funds and large institutions have $1.63M invested in ProShares Ultra NASDAQ Biotechnology in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
Holders
17
Holders Change
-6
Holders Change %
-26.09%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–